Literature DB >> 3887616

Adjuvant therapy in primary breast cancer.

N Wolmark, B Fisher.   

Abstract

This article considers the role of adjuvant therapy in primary breast cancer, utilizing data from randomized prospective clinical trials as illustrative examples. The ongoing efforts targeted toward addressing some of the unresolved issues are underscored.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3887616     DOI: 10.1016/s0039-6109(16)43540-1

Source DB:  PubMed          Journal:  Surg Clin North Am        ISSN: 0039-6109            Impact factor:   2.741


  1 in total

1.  Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF + tamoxifen in a single centre.

Authors:  L Mauriac; M Durand; J Chauvergne; F Bonichon; A Avril; P Mage; M H Dilhuydy; A Le Treut; J Wafflart; D Marée
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.